BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19394156)

  • 1. Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas.
    Hristov B; Reddy S; Lin SH; Cameron JL; Pawlik TM; Hruban RH; Swartz MJ; Edil BH; Kemp C; Wolfgang CL; Herman JM
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):176-80. PubMed ID: 19394156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
    Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
    Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grafts for mesenterico-portal vein resections can be avoided during pancreatoduodenectomy.
    Wang F; Arianayagam R; Gill A; Puttaswamy V; Neale M; Gananadha S; Hugh TJ; Samra JS
    J Am Coll Surg; 2012 Oct; 215(4):569-79. PubMed ID: 22762991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
    Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
    Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreaticoduodenectomy with vascular resection: margin status and survival duration.
    Tseng JF; Raut CP; Lee JE; Pisters PW; Vauthey JN; Abdalla EK; Gomez HF; Sun CC; Crane CH; Wolff RA; Evans DB
    J Gastrointest Surg; 2004 Dec; 8(8):935-49; discussion 949-50. PubMed ID: 15585381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience.
    Menon VG; Puri VC; Annamalai AA; Tuli R; Nissen NN
    Am Surg; 2013 Oct; 79(10):1064-7. PubMed ID: 24160800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head.
    Carrère N; Sauvanet A; Goere D; Kianmanesh R; Vullierme MP; Couvelard A; Ruszniewski P; Belghiti J
    World J Surg; 2006 Aug; 30(8):1526-35. PubMed ID: 16855797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
    Hsu CC; Herman JM; Corsini MM; Winter JM; Callister MD; Haddock MG; Cameron JL; Pawlik TM; Schulick RD; Wolfgang CL; Laheru DA; Farnell MB; Swartz MJ; Gunderson LL; Miller RC
    Ann Surg Oncol; 2010 Apr; 17(4):981-90. PubMed ID: 20087786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
    Herman JM; Swartz MJ; Hsu CC; Winter J; Pawlik TM; Sugar E; Robinson R; Laheru DA; Jaffee E; Hruban RH; Campbell KA; Wolfgang CL; Asrari F; Donehower R; Hidalgo M; Diaz LA; Yeo C; Cameron JL; Schulick RD; Abrams R
    J Clin Oncol; 2008 Jul; 26(21):3503-10. PubMed ID: 18640931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.
    Zhao X; Li LX; Fan H; Kou JT; Li XL; Lang R; He Q
    J Int Med Res; 2016 Dec; 44(6):1339-1348. PubMed ID: 28322103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie.
    Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F
    Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma.
    Kim PT; Wei AC; Atenafu EG; Cavallucci D; Cleary SP; Moulton CA; Greig PD; Gallinger S; Serra S; McGilvray ID
    Br J Surg; 2013 Sep; 100(10):1349-56. PubMed ID: 23939847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.
    Riediger H; Makowiec F; Fischer E; Adam U; Hopt UT
    J Gastrointest Surg; 2006; 10(8):1106-15. PubMed ID: 16966029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transverse closure of mesenterico-portal vein after vein resection in pancreatoduodenectomy.
    Chua TC; de Reuver PR; Staerkle RF; Neale ML; Arena J; Mittal A; Shanbhag ST; Gill AJ; Samra JS
    Eur J Surg Oncol; 2016 Feb; 42(2):211-8. PubMed ID: 26456791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferior mesenteric vein serves as an alternative guide for transection of the pancreatic body during pancreaticoduodenectomy with concomitant vascular resection: a comparative study evaluating perioperative outcomes.
    Chen Y; Wang X; Ke N; Mai G; Liu X
    Eur J Med Res; 2014 Aug; 19(1):42. PubMed ID: 25141915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.
    Leach SD; Lee JE; Charnsangavej C; Cleary KR; Lowy AM; Fenoglio CJ; Pisters PW; Evans DB
    Br J Surg; 1998 May; 85(5):611-7. PubMed ID: 9635805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of pancreaticoduodenectomy with superior mesenteric and portal vein resection for ductal adenocarcinoma in the head of the pancreas.
    Landi F; Dopazo C; Sapisochin G; Beisani M; Blanco L; Caralt M; Balsells J; Charco R
    Cir Esp; 2015 Oct; 93(8):522-9. PubMed ID: 25981612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    You DD; Lee HG; Heo JS; Choi SH; Choi DW
    J Gastrointest Surg; 2009 Sep; 13(9):1699-706. PubMed ID: 19582512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreaticoduodenectomy with mesenterico-portal vein resection (with video).
    Pessaux P; Méméo R; Ferreira N; Hargat J; Mutter D; Marescaux J
    J Visc Surg; 2016 Jun; 153(3):227-8. PubMed ID: 27032317
    [No Abstract]   [Full Text] [Related]  

  • 20. Mesenterico-portal vein resection in patients with pancreatico-duodenal cancer is safe and may increase survival.
    Storkholm JH; Hansen CP
    Dan Med J; 2014 Jan; 61(1):A4757. PubMed ID: 24393587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.